USPTO serial 79439126
Reviewed by CopyMark Law Group
Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Theodore R. Remaklus
Theodore R. Remaklus Thompson Hine LLP312 Walnut Street, Suite 2000Cincinnati, OH 45202-4024United States| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceuticals, medical and veterinary preparations for the prevention and treatment of pain, cancer, and neurological, neurodevelopmental, neurodegenerative, ophthalmic, otic, musculoskeletal and joint disease or disorders; Diagnostic reagents for medical use; diagnostic agents for pharmaceutical use; Hygienic products for medical purposes, namely, disinfectants for hygiene purposes; Dietetic food and substances in the nature of fatty acids, amino acids and nutraceutical preparations adapted for medical and veterinary use, food for babies; Dietary supplements for human beings and animals; Plasters for medical purposes, materials for dressings, namely, wound dressings; Material for stopping teeth, dental wax; Disinfectants | ACTIVE | — |
| 041 | Education services, namely, providing seminars, workshops and conferences in the fields of health and disease prevention and treatment, specifically in neurology, ophthalmology, otology, oncology, pain management, and musculoskeletal and joint diseases and disorders; providing of training in the fields of health and disease prevention and treatment, specifically in neurology, ophthalmology, otology, oncology, pain management, and musculoskeletal and joint diseases and disorders; organizing community sporting and cultural events; organization of events, courses, seminars, conferences, and congresses in the field of pharmaceuticals, medicine and science for educational and cultural purposes; publication of scientific documents | ACTIVE | — |
| 042 | Scientific and technological services and research and design relating thereto, namely, scientific research and analysis services in the field of pharmaceuticals and medicine; Industrial analysis, industrial research and industrial design services in the field of pharmaceuticals and medicine, namely, conducting early evaluations in the field of new pharmaceuticals and design of laboratory protocols and industrial processes for pharmaceutical development; Quality control of the goods and services of others and authentication services in the field of pharmaceuticals and medicine; Design and development of computer hardware and software; Pharmaceutical research services; Pharmaceutical testing | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 13, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 13, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 7, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 17, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 17, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 17, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 17, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 17, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 21, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 21, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 21, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 1, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| May 14, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 28, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 28, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 19, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 18, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 16, 2026 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| Mar 13, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 13, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 13, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 12, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 10, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 15, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 15, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 11, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |